Endo International plc — Ethics Grade F

Endo International plc receives an overall ethics grade of F (12/100) on CancelCo's corporate accountability database. Sector: Pharmaceuticals. Market cap: Mid Cap.

Category scores

• labor: 40
• privacy: 70
• consumer: 5
• environment: 50
• humanRights: 30

Documented incidents (3)

• Opioid Litigation Settlement (high, 2022) — Endo filed for bankruptcy as part of a settlement to resolve thousands of lawsuits alleging it deceptively marketed opioid painkillers, contributing to the addiction epidemic. The company was accused of downplaying the drug's addictive qualities.
• Generic Drug Price Fixing (high, 2020) — The company was implicated in a multi-state investigation into a widespread conspiracy among generic manufacturers to artificially inflate prices and reduce competition. This led to significantly higher costs for essential medications.
• Vaginal Mesh Injuries (high, 2021) — The company paid hundreds of millions to settle claims regarding surgical mesh products that caused severe internal injuries to thousands of women. Internal documents suggested the company knew of risks.

Documented good deeds

• STEM Career Support — Endo participated in local community grants to support science and technology education in underserved districts near its operations.

Ethical alternatives

• Organon & Co — Focuses on women's health with a cleaner litigation profile regarding consumer protection.